Corti AI Confirms IPO Plans, Rules Out 2026 Launch

Corti, a Copenhagen-based AI pioneer in healthcare, has confirmed plans for an initial public offering (IPO) but explicitly ruled out 2026 as the target year. This announcement was made by the CEO in a recent CNBC interview, highlighting the company's strategic approach amid growing demand for AI tools in medical workflows.

Company Background and Core Technology

Founded in 2016, Corti specializes in artificial intelligence models for the healthcare sector. The company focuses on understanding complex medical terminology, patient interactions, and clinical workflows. Its platform integrates via application programming interfaces (APIs) into existing healthcare applications, enabling real-time analysis of conversations, triage decisions, and documentation automation.

Corti's technology excels in processing audio from ambulance calls, doctor-patient dialogues, and telehealth sessions. For instance, its AI can detect subtle clinical cues, such as changes in speech patterns indicating cardiac arrest, faster than human operators. This capability is based on proprietary large language models trained on vast datasets of anonymized medical interactions.

CEO's IPO Revelation and Strategic Context

In the CNBC interview aired on December 30, 2025, Corti's CEO confirmed plans to go public while dismissing 2026 as premature. The CEO emphasized the need for sustained revenue growth and market validation before listing. This decision aligns with Corti's recent milestones, including partnerships with major European health systems and expansions into the U.S. market.

Funding Trajectory and Market Positioning

Corti has secured substantial venture backing, though exact figures are less publicized than those of U.S. counterparts. Its funding supports research and development into multimodal AI, combining speech, text, and vital signs for comprehensive clinical support.

Competitive Landscape and Challenges

Corti operates in a competitive arena with rivals like Abridge and Suki. Its strength lies in non-English language proficiency and an emphasis on ethical AI. Challenges include regulatory hurdles from the EU AI Act and data scarcity in niche medical scenarios.

Industry Impact and Future Outlook

Corti’s trajectory signals a maturing AI healthcare sector. By automating routine tasks, such platforms could alleviate global clinician shortages. The IPO delay allows Corti to capture more market share, potentially listing on Nasdaq or Euronext in 2027-2028.

Industry statistics: AI in healthcare adoption has surged 40% year-over-year, with conversational AI reducing clinician burnout by up to 30% through automated note-taking.

Key visual: Infographic of Corti’s AI workflow – Flowchart depicting audio input → AI analysis → clinical outputs, with icons for ambulance integration and hospital dashboards.